According to IMARC Group latest report titled “Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on oxygen therapy market demand. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample

Oxygen Therapy Market Overview:

Oxygen therapy is a medical intervention that provides supplementary oxygen to individuals experiencing low oxygen levels in their blood, a condition known as hypoxemia. This therapeutic practice encompasses various systems, including oxygen concentrators, compressed oxygen cylinders, liquid oxygen devices, and hyperbaric oxygen chambers, tailored to individual patient needs. The therapy is pivotal in managing various medical conditions, such as chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and sleep apnea, enhancing patients' life quality by improving oxygen availability, supporting cellular functions, and alleviating symptoms of oxygen deprivation. Additionally, its advantages are significant, offering improved respiratory function, enhanced mental clarity, increased stamina, and overall better health outcomes, thereby underscoring its essential role in contemporary medical care.

Oxygen Therapy Market Trends:

The global market is witnessing substantial growth, propelled by the rising prevalence of respiratory disorders, such as COPD, asthma, and obstructive sleep apnea, alongside an aging global population increasingly susceptible to such ailments. Along with this, technological advancements in oxygen delivery systems, including portable and user-friendly devices, are expanding the therapy's accessibility and convenience, thereby enhancing patient adherence and improving outcomes. In addition, the ongoing COVID-19 pandemic is also influencing the importance of respiratory care, with oxygen therapy being crucial for managing severe cases, thus driving urgent demand and innovation in the sector. Apart from this, healthcare infrastructure improvements, increased healthcare expenditure, and accelerating awareness regarding the benefits of early oxygen therapy intervention are trends contributing to the market's expansion. Furthermore, government initiatives promoting respiratory health and ensuring the availability of oxygen therapy devices are also instrumental in catalyzing market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players operating in the market.

  • Allied Healthcare Products Inc.
  • Becton Dickinson and Company
  • DeVilbiss Healthcare LLC (Drive Medical Inc.)
  • Fisher & Paykel Healthcare Limited
  • General Electric Company
  • Getinge AB
  • Hersill SL
  • Invacare Corporation
  • Koninklijke Philips N.V
  • Smiths Group plc
  • Tecno-Gaz S.p.A.
  • Teleflex Incorporated

Oxygen Therapy Market Segmentation:

Our report has categorized the market based on region, product, application and end use.

Breakup by Product:

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
    • PAP Devices
  • Oxygen Delivery Devices
    • Oxygen Masks
    • Nasal Cannula
    • Venturi Masks
    • Non-rebreather Masks
    • Bag Valve Masks
    • CPAP Masks
    • Others

Breakup by Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others

Breakup by End Use:

  • Home Healthcare
  • Hospitals

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)
  • Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
  • Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Key Highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163